Skip to main content
. 2023 Aug 1;9(4):44. doi: 10.3390/ncrna9040044
ALL Acute lymphocytic leukemia
BL Burkitt’s lymphoma
CASC15 Cancer susceptibility candidate 15
CLL Chronic lymphocytic leukemia
DDX5 DEAD-box RNA helicase
DLBCL Diffuse large B-cell lymphoma
FLICR Foxp3 long intergenic noncoding RNA
Flatr Foxp3-specific lncRNA anticipatory of Tregs
FL Follicular lymphoma
GAS5 Growth arrest-specific 5
HSC Hematopoietic stem cells
HOTAIR Hox transcript antisense intergenic RNA
HOTTIP HOXA transcript at the distal tip
HOXA-AS2 HOXA cluster antisense RNA 2
IFNγ-AS1 Interferon gamma antisense RNA 1
LncRNAs Long non-coding RNAs
LEF1-AS1 Lymphoid enhancer-binding factor 1-antisense RNA 1
MALAT1 Metastasis associated lung adenocarcinoma transcript 1
MEG3 Maternally expressed gene 3
MYB-AS1 MYB antisense RNA 1
MIAT Myocardial infarction associated transcript
MCL Mantle-cell lymphoma
mTOR Mammalian target of rapamycin
NcRNAs Non-coding RNAs
NK cell Natural killer cell
NEAT1 Nuclear enriched abundant transcript 1
NHL Non-Hodgkin lymphoma
NKTCL Natural killer/T-cell lymphoma
PAIR PAX5-activated intergenic repeat
PANDA P21-associated ncRNA DNA damage-activated
PRC2 Polycomb repressive complex 2
PI3K Phosphatidylinositol 3-kinase
PiRNAs PIWI-interacting RNAs
RNASeq RNA-sequencing
RT-PCR Reverse transcription polymerase chain reaction
SncRNAs Small non-coding RNAs
SiRNAs Small interfering RNAs
SMAD1-AS1 SMAD1 antisense RNA 1
ShRNA Short hairpin RNA
XIST X-inactive specific transcript